Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

SP-D-dependent regulation of NO metabolism in lipopolysaccharide-stimulated peritoneal macrophages.

Atochina-Vasserman EN, Abramova EV, Tomer Y, Scott P, Nazarov VA, Kruglov SV, Beers MF, Gow AJ, Malyshev IY.

Bull Exp Biol Med. 2009 Apr;147(4):415-20. English, Russian.

2.

Radiation-induced lung injury and inflammation in mice: role of inducible nitric oxide synthase and surfactant protein D.

Malaviya R, Gow AJ, Francis M, Abramova EV, Laskin JD, Laskin DL.

Toxicol Sci. 2015 Mar;144(1):27-38. doi: 10.1093/toxsci/kfu255. Epub 2014 Dec 30.

3.

Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages.

Stamme C, Walsh E, Wright JR.

Am J Respir Cell Mol Biol. 2000 Dec;23(6):772-9.

PMID:
11104730
4.

Mite allergen induces nitric oxide production in alveolar macrophage cell lines via CD14/toll-like receptor 4, and is inhibited by surfactant protein D.

Liu CF, Chen YL, Chang WT, Shieh CC, Yu CK, Reid KB, Wang JY.

Clin Exp Allergy. 2005 Dec;35(12):1615-24.

PMID:
16393328
5.

Nitric oxide mediates relative airway hyporesponsiveness to lipopolysaccharide in surfactant protein A-deficient mice.

Pastva AM, Walker JK, Maddox LA, Mukherjee S, Giamberardino C, Hsia B, Potts E, Zhu H, Degan S, Sunday ME, Lawson BL, Korfhagen TR, Schwartz DA, Eu JP, Foster WM, McMahon TJ, Que L, Wright JR.

Am J Respir Cell Mol Biol. 2011 Feb;44(2):175-84. doi: 10.1165/rcmb.2009-0284OC. Epub 2010 Mar 26. Retraction in: Am J Respir Cell Mol Biol. 2016 Nov;55(5):758.

6.

Response of alveolar macrophages from inducible nitric oxide synthase knockout or wild-type mice to an in vitro lipopolysaccharide or silica exposure.

Zeidler PC, Roberts JR, Castranova V, Chen F, Butterworth L, Andrew ME, Robinson VA, Porter DW.

J Toxicol Environ Health A. 2003 Jun 13;66(11):995-1013.

PMID:
12775513
9.
10.

Immunosuppressive properties of surfactant in alveolar macrophage NR8383.

Kerecman J, Mustafa SB, Vasquez MM, Dixon PS, Castro R.

Inflamm Res. 2008 Mar;57(3):118-25. doi: 10.1007/s00011-007-7212-1.

PMID:
18369576
11.

Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism.

Atochina EN, Beers MF, Hawgood S, Poulain F, Davis C, Fusaro T, Gow AJ.

Am J Respir Cell Mol Biol. 2004 Mar;30(3):271-9. Epub 2003 Jul 18.

PMID:
12871850
12.

Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models.

Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N.

Lipids Health Dis. 2011 Oct 12;10:177. doi: 10.1186/1476-511X-10-177.

13.

Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages.

Miles PR, Bowman L, Rao KM, Baatz JE, Huffman L.

Am J Physiol. 1999 Jan;276(1 Pt 1):L186-96.

14.

Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.

Kang JS, Jeon YJ, Kim HM, Han SH, Yang KH.

J Pharmacol Exp Ther. 2002 Jul;302(1):138-44.

15.

The essential role of Oct-2 in LPS-induced expression of iNOS in RAW 264.7 macrophages and its regulation by trichostatin A.

Lu SC, Wu HW, Lin YJ, Chang SF.

Am J Physiol Cell Physiol. 2009 May;296(5):C1133-9. doi: 10.1152/ajpcell.00031.2009. Epub 2009 Mar 11.

16.

PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.

Paukkeri EL, Leppänen T, Sareila O, Vuolteenaho K, Kankaanranta H, Moilanen E.

Br J Pharmacol. 2007 Dec;152(7):1081-91. Epub 2007 Sep 24.

17.
18.

NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis.

Knudsen L, Atochina-Vasserman EN, Guo CJ, Scott PA, Haenni B, Beers MF, Ochs M, Gow AJ.

PLoS One. 2014 Jan 21;9(1):e85722. doi: 10.1371/journal.pone.0085722. eCollection 2014 Jan 21.

19.

Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin.

Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N.

Lipids Health Dis. 2011 Dec 20;10:239. doi: 10.1186/1476-511X-10-239.

20.

Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.

Zhou R, Zheng SX, Tang W, He PL, Li XY, Yang YF, Li YC, Geng JG, Zuo JP.

J Pharmacol Exp Ther. 2006 Jan;316(1):121-8. Epub 2005 Sep 15.

Supplemental Content

Support Center